Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $11.49 billion. The enterprise value is $7.87 billion.
| Market Cap | 11.49B |
| Enterprise Value | 7.87B |
Important Dates
The next confirmed earnings date is Tuesday, April 30, 2024, before market open.
| Earnings Date | Apr 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Incyte has 224.53 million shares outstanding. The number of shares has increased by 0.88% in one year.
| Shares Outstanding | 224.53M |
| Shares Change (YoY) | +0.88% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 1.58% |
| Owned by Institutions (%) | 99.97% |
| Float | 186.98M |
Valuation Ratios
The trailing PE ratio is 19.31 and the forward PE ratio is 11.13. Incyte's PEG ratio is 0.69.
| PE Ratio | 19.31 |
| Forward PE | 11.13 |
| PS Ratio | 3.11 |
| Forward PS | 2.73 |
| PB Ratio | 2.21 |
| P/FCF Ratio | 24.77 |
| PEG Ratio | 0.69 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.56, with an EV/FCF ratio of 16.95.
| EV / Earnings | 13.16 |
| EV / Sales | 2.13 |
| EV / EBITDA | 8.56 |
| EV / EBIT | 9.40 |
| EV / FCF | 16.95 |
Financial Position
The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.75 |
| Quick Ratio | 3.55 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.07 |
| Interest Coverage | 328.01 |
Financial Efficiency
Return on equity (ROE) is 12.40% and return on invested capital (ROIC) is 8.51%.
| Return on Equity (ROE) | 12.40% |
| Return on Assets (ROA) | 9.50% |
| Return on Capital (ROIC) | 8.51% |
| Revenue Per Employee | $1.46M |
| Profits Per Employee | $236,767 |
| Employee Count | 2,524 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 1.30 |
Taxes
In the past 12 months, Incyte has paid $236.62 million in taxes.
| Income Tax | 236.62M |
| Effective Tax Rate | 28.36% |
Stock Price Statistics
The stock price has decreased by -30.41% in the last 52 weeks. The beta is 0.67, so Incyte's price volatility has been lower than the market average.
| Beta (1Y) | 0.67 |
| 52-Week Price Change | -30.41% |
| 50-Day Moving Average | 56.94 |
| 200-Day Moving Average | 59.22 |
| Relative Strength Index (RSI) | 20.70 |
| Average Volume (30 Days) | 1,756,574 |
Short Selling Information
The latest short interest is 8.27 million, so 3.68% of the outstanding shares have been sold short.
| Short Interest | 8.27M |
| Short Previous Month | 8.06M |
| Short % of Shares Out | 3.68% |
| Short % of Float | 4.42% |
| Short Ratio (days to cover) | 4.27 |
Income Statement
In the last 12 months, Incyte had revenue of $3.70 billion and earned $597.60 million in profits. Earnings per share was $2.65.
| Revenue | 3.70B |
| Gross Profit | 3.44B |
| Operating Income | 620.53M |
| Pretax Income | 834.22M |
| Net Income | 597.60M |
| EBITDA | 919.43M |
| EBIT | 836.77M |
| Earnings Per Share (EPS) | $2.65 |
Balance Sheet
The company has $3.66 billion in cash and $32.60 million in debt, giving a net cash position of $3.63 billion or $16.15 per share.
| Cash & Cash Equivalents | 3.66B |
| Total Debt | 32.60M |
| Net Cash | 3.63B |
| Net Cash Per Share | $16.15 |
| Equity / Book Value | 5.19B |
| Book Value Per Share | 23.11 |
| Working Capital | 3.41B |
Cash Flow
In the last 12 months, operating cash flow was $496.49 million and capital expenditures -$32.49 million, giving a free cash flow of $464.00 million.
| Operating Cash Flow | 496.49M |
| Capital Expenditures | -32.49M |
| Free Cash Flow | 464.00M |
| FCF Per Share | $2.08 |
Margins
Gross margin is 93.10%, with operating and profit margins of 16.79% and 16.17%.
| Gross Margin | 93.10% |
| Operating Margin | 16.79% |
| Pretax Margin | 22.57% |
| Profit Margin | 16.17% |
| EBITDA Margin | 24.88% |
| EBIT Margin | 22.64% |
| FCF Margin | 12.56% |
Dividends & Yields
Incyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.88% |
| Shareholder Yield | -0.88% |
| Earnings Yield | 5.20% |
| FCF Yield | 4.04% |
Analyst Forecast
The average price target for Incyte is $74.69, which is 45.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $74.69 |
| Price Target Difference | 45.94% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 8.52% |
| EPS Growth Forecast (5Y) | 25.60% |
Stock Splits
The last stock split was on September 1, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 1, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Incyte has an Altman Z-Score of 5.92 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.92 |
| Piotroski F-Score | 5 |